Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Sep;63(9):3241–3244. doi: 10.1128/iai.63.9.3241-3244.1995

Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

C E Taylor 1
PMCID: PMC173446  PMID: 7543878

Abstract

The use of cytokines in the administration of vaccines has a unique value in obtaining the appropriate immune response and in ensuring a protective outcome. Earlier studies indicating that cytokines can influence the generation of a particular antibody isotype may represent an oversimplification of a more complex problem. Several studies discussed in this review show that the effect of a given cytokine on the immune response depends on whether one examines the antigen-specific response or the polyclonal response (i.e., total serum immunoglobulins). Further, a balanced regulation of immune responsiveness is important in maintaining homeostasis of the immune system. Consequently, for any vaccine that uses cytokines to boost the response, due consideration must be given to these important variables.

Full Text

The Full Text of this article is available as a PDF (166.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afonso L. C., Scharton T. M., Vieira L. Q., Wysocka M., Trinchieri G., Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 1994 Jan 14;263(5144):235–237. doi: 10.1126/science.7904381. [DOI] [PubMed] [Google Scholar]
  2. Baker P. J., Hraba T., Taylor C. E., Stashak P. W., Fauntleroy M. B., Zähringer U., Takayama K., Sievert T. R., Hronowski X., Cotter R. J. Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides. Infect Immun. 1994 Jun;62(6):2257–2269. doi: 10.1128/iai.62.6.2257-2269.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker P. J. Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infect Immun. 1990 Nov;58(11):3465–3468. doi: 10.1128/iai.58.11.3465-3468.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barrett D. J., Sleasman J. W., Schatz D. A., Steinitz M. Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage. Cell Immunol. 1992 Aug;143(1):66–79. doi: 10.1016/0008-8749(92)90006-b. [DOI] [PubMed] [Google Scholar]
  5. Beck L., Spiegelberg H. L. The polyclonal and antigen-specific IgE and IgG subclass response of mice injected with ovalbumin in alum or complete Freund's adjuvant. Cell Immunol. 1989 Oct 1;123(1):1–8. doi: 10.1016/0008-8749(89)90263-3. [DOI] [PubMed] [Google Scholar]
  6. Bossie A., Vitetta E. S. IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching. Cell Immunol. 1991 Jun;135(1):95–104. doi: 10.1016/0008-8749(91)90257-c. [DOI] [PubMed] [Google Scholar]
  7. Costelloe K. E., Smith S. H., Callard R. E. Interleukin 6 is not required for antigen-specific antibody responses by human B cells. Eur J Immunol. 1993 Apr;23(4):984–987. doi: 10.1002/eji.1830230436. [DOI] [PubMed] [Google Scholar]
  8. Coutelier J. P., van der Logt J. T., Heessen F. W., Warnier G., Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med. 1987 Jan 1;165(1):64–69. doi: 10.1084/jem.165.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Czarniecki C. W., Sonnenfeld G. Interferon-gamma and resistance to bacterial infections. APMIS. 1993 Jan;101(1):1–17. doi: 10.1111/j.1699-0463.1993.tb00073.x. [DOI] [PubMed] [Google Scholar]
  10. Fauntleroy M. B., Asofsky R., Baker P. J., Hraba T., Brooks A., Stashak P., Taylor C. E. Effects of IL-4 depletion on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice. Immunobiology. 1993 Aug;188(4-5):379–391. doi: 10.1016/S0171-2985(11)80221-4. [DOI] [PubMed] [Google Scholar]
  11. Fauntleroy M. B., Rudbach J. A., Prescott B., Baker P. J. Increased activation of antigen-primed or memory B cells by bacterial lipopolysaccharide. Cell Immunol. 1987 Jul;107(2):263–272. doi: 10.1016/0008-8749(87)90235-8. [DOI] [PubMed] [Google Scholar]
  12. Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr, Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. doi: 10.1146/annurev.iy.08.040190.001511. [DOI] [PubMed] [Google Scholar]
  13. Finkelman F. D., Katona I. M., Mosmann T. R., Coffman R. L. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol. 1988 Feb 15;140(4):1022–1027. [PubMed] [Google Scholar]
  14. Finnemann S., Kremsner P. G., Chaves M. F., Schumacher C., Neifer S., Bienzle U. Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma. Parasitol Res. 1992;78(8):629–634. doi: 10.1007/BF00931511. [DOI] [PubMed] [Google Scholar]
  15. Gascan H., Gauchat J. F., Roncarolo M. G., Yssel H., Spits H., de Vries J. E. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med. 1991 Mar 1;173(3):747–750. doi: 10.1084/jem.173.3.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Granholm N. A., Cavallo T. Autoimmunity, polyclonal B-cell activation and infection. Lupus. 1992 Feb;1(2):63–74. doi: 10.1177/096120339200100203. [DOI] [PubMed] [Google Scholar]
  17. Gustafson G. L., Rhodes M. J. Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity. Res Immunol. 1992 Jun;143(5):483–574. doi: 10.1016/0923-2494(92)80058-s. [DOI] [PubMed] [Google Scholar]
  18. Harriman G. R., Hörnqvist E., Lycke N. Y. Antigen-specific and polyclonal CD4+ lamina propria T-cell lines: phenotypic and functional characterization. Immunology. 1992 Jan;75(1):66–73. [PMC free article] [PubMed] [Google Scholar]
  19. Haruna K., Hikida M., Ohmori H. Antigen-specific but not polyclonal IgE response in murine B cells cocultured with Th2 clone is refractory to suppression by IL4-depletion. Int Arch Allergy Immunol. 1993;102(2):152–159. doi: 10.1159/000236566. [DOI] [PubMed] [Google Scholar]
  20. Indraccolo S., Mion M., Zamarchi R., Veronesi A., Veronese M. L., Panozzo M., Betterle C., Barelli A., Borri A., Amadori A. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets. J Clin Immunol. 1993 Nov;13(6):381–388. doi: 10.1007/BF00920013. [DOI] [PubMed] [Google Scholar]
  21. Jyonouchi H., Zhang L., Tomita Y. Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr Cancer. 1993;19(3):269–280. doi: 10.1080/01635589309514258. [DOI] [PubMed] [Google Scholar]
  22. Katz I. R., Krown S. E., Safai B., Oettgen H. F., Hoffmann M. K. Antigen-specific and polyclonal B-cell responses in patients with acquired immunodeficiency disease syndrome. Clin Immunol Immunopathol. 1986 Jun;39(3):359–367. doi: 10.1016/0090-1229(86)90164-9. [DOI] [PubMed] [Google Scholar]
  23. Kirschmann D. A., Murasko D. M. Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cell Immunol. 1992 Feb;139(2):426–437. doi: 10.1016/0008-8749(92)90083-2. [DOI] [PubMed] [Google Scholar]
  24. Kulkarni A. B., Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol. 1993 Jul;143(1):3–9. [PMC free article] [PubMed] [Google Scholar]
  25. Kurosaki T., Takata M., Yamanashi Y., Inazu T., Taniguchi T., Yamamoto T., Yamamura H. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J Exp Med. 1994 May 1;179(5):1725–1729. doi: 10.1084/jem.179.5.1725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Körner M., Tarantino N., Pleskoff O., Lee L. M., Debré P. Activation of nuclear factor kappa B in human neuroblastoma cell lines. J Neurochem. 1994 May;62(5):1716–1726. doi: 10.1046/j.1471-4159.1994.62051716.x. [DOI] [PubMed] [Google Scholar]
  27. Kühn R., Rajewsky K., Müller W. Generation and analysis of interleukin-4 deficient mice. Science. 1991 Nov 1;254(5032):707–710. doi: 10.1126/science.1948049. [DOI] [PubMed] [Google Scholar]
  28. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  29. Lebman D. A., Nomura D. Y., Coffman R. L., Lee F. D. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S A. 1990 May;87(10):3962–3966. doi: 10.1073/pnas.87.10.3962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lucchiari M. A., Modolell M., Eichmann K., Pereira C. A. In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection. Immunobiology. 1992 Sep;185(5):475–482. doi: 10.1016/S0171-2985(11)80089-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McGhee J. R., Fujihashi K., Lue C., Beagley K. W., Mestecky J., Kiyono H. Role of IL-6 in human antigen-specific and polyclonal IgA responses. Adv Exp Med Biol. 1991;310:113–121. doi: 10.1007/978-1-4615-3838-7_13. [DOI] [PubMed] [Google Scholar]
  32. Nakao M., Hazama M., Mayumi-Aono A., Hinuma S., Fujisawa Y. Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein. J Infect Dis. 1994 Apr;169(4):787–791. doi: 10.1093/infdis/169.4.787. [DOI] [PubMed] [Google Scholar]
  33. Nash A. D., Lofthouse S. A., Barcham G. J., Jacobs H. J., Ashman K., Meeusen E. N., Brandon M. R., Andrews A. E. Recombinant cytokines as immunological adjuvants. Immunol Cell Biol. 1993 Oct;71(Pt 5):367–379. doi: 10.1038/icb.1993.43. [DOI] [PubMed] [Google Scholar]
  34. Nauciel C., Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun. 1992 Feb;60(2):450–454. doi: 10.1128/iai.60.2.450-454.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. O'Garra A., Chang R., Go N., Hastings R., Haughton G., Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol. 1992 Mar;22(3):711–717. doi: 10.1002/eji.1830220314. [DOI] [PubMed] [Google Scholar]
  36. Ohmori H., Hikida M., Haruna K., Kishimoto T. In vitro antigen-specific IgE response is refractory to suppression by interferon-gamma. Immunol Lett. 1992 Oct-Nov;34(2):99–104. doi: 10.1016/0165-2478(92)90234-f. [DOI] [PubMed] [Google Scholar]
  37. Pasatiempo A. M., Kinoshita M., Taylor C. E., Ross A. C. Antibody production in vitamin A-depleted rats is impaired after immunization with bacterial polysaccharide or protein antigens. FASEB J. 1990 May;4(8):2518–2527. doi: 10.1096/fasebj.4.8.2110538. [DOI] [PubMed] [Google Scholar]
  38. Paul W. E. Cytokines. Poking holes in the network. Nature. 1992 May 7;357(6373):16–17. doi: 10.1038/357016a0. [DOI] [PubMed] [Google Scholar]
  39. Petersen J. Inhibition of T cell-dependent antibody production by D-penicillamine. Different requirements for Cu2+ in suppression of polyclonal and antigen-specific B cell responses. Allergy. 1987 Jan;42(1):37–45. doi: 10.1111/j.1398-9995.1987.tb02185.x. [DOI] [PubMed] [Google Scholar]
  40. Powrie F., Coffman R. L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Trends Pharmacol Sci. 1993 May;14(5):164–168. doi: 10.1016/0165-6147(93)90202-u. [DOI] [PubMed] [Google Scholar]
  41. Rolland L., Ballet J. J., Daniel-Ribeiro C. Kinetics of antigen specific and non-specific polyclonal B-cell responses during lethal Plasmodium yoelii malaria. Mem Inst Oswaldo Cruz. 1992 Apr-Jun;87(2):197–204. doi: 10.1590/s0074-02761992000200005. [DOI] [PubMed] [Google Scholar]
  42. Taylor C. E., Baker P. J., Hraba T., Stashak P., Fauntleroy M. B. Effects of interferon gamma on the antibody response to Pseudomonas aeruginosa lipopolysaccharide in mice. Immunobiology. 1994 Dec;192(1-2):106–120. doi: 10.1016/S0171-2985(11)80411-0. [DOI] [PubMed] [Google Scholar]
  43. Taylor C. E., Fauntleroy M. B., Stashak P. W., Baker P. J. Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines. Infect Immun. 1991 Feb;59(2):575–579. doi: 10.1128/iai.59.2.575-579.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Trifiletti R., Hyman B., LaVia M., Knapp W., Virella G. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells. Scand J Immunol. 1990 Jan;31(1):25–31. doi: 10.1111/j.1365-3083.1990.tb02739.x. [DOI] [PubMed] [Google Scholar]
  45. Wakatsuki Y., Neurath M. F., Max E. E., Strober W. The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med. 1994 Apr 1;179(4):1099–1108. doi: 10.1084/jem.179.4.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wallis R. S., Ellner J. J. Cytokines and tuberculosis. J Leukoc Biol. 1994 May;55(5):676–681. doi: 10.1002/jlb.55.5.676. [DOI] [PubMed] [Google Scholar]
  47. van Ommen R., Vredendaal A. E., Savelkoul H. F. Prolonged in vivo IL-4 treatment inhibits antigen-specific IgG1 and IgE formation. Scand J Immunol. 1994 Jul;40(1):1–9. doi: 10.1111/j.1365-3083.1994.tb03425.x. [DOI] [PubMed] [Google Scholar]
  48. van Ommen R., Vredendaal A. E., Savelkoul H. F. Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo. Eur J Immunol. 1994 Jun;24(6):1396–1403. doi: 10.1002/eji.1830240624. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES